Agboola, O. E., Ayinla, Z. A., Agboola, S. S., Omolayo, E. Y., Fadugba, A. E., Odeghe, O. B., . . . Oyinloye, B. E. In silico profiling of neem limonoids and gut microbiome metabolites for Alzheimer’s therapeutics: Targeted inhibition of BACE1 and elucidation of intricate molecular crosstalk with tau oligomers, and bacterial gingipains. Springer.
Chicago Style (17th ed.) CitationAgboola, Oluwaseun E., Zainab A. Ayinla, Samuel S. Agboola, Esther Y. Omolayo, Abimbola E. Fadugba, Othuke B. Odeghe, Oluranti E. Olaiya, and Babatunji E. Oyinloye. In Silico Profiling of Neem Limonoids and Gut Microbiome Metabolites for Alzheimer’s Therapeutics: Targeted Inhibition of BACE1 and Elucidation of Intricate Molecular Crosstalk with Tau Oligomers, and Bacterial Gingipains. Springer.
MLA (9th ed.) CitationAgboola, Oluwaseun E., et al. In Silico Profiling of Neem Limonoids and Gut Microbiome Metabolites for Alzheimer’s Therapeutics: Targeted Inhibition of BACE1 and Elucidation of Intricate Molecular Crosstalk with Tau Oligomers, and Bacterial Gingipains. Springer.